Cleary Gottlieb Steen & Hamilton yesterday announced plans to launch a Hong Kong law practice with a partner recruited from U.K. firm Norton Rose. Freeman Chan, an experienced capital markets lawyer, now heads the China corporate finance practice at the U.K. firm. He has acted as issuer’s counsel in several recent Hong Kong initial public offerings, including the $741 million debut of Sihuan Pharmaceutical in October and the $450 million IPO of China Modern Dairy in November.
“We are excited that Freeman, an acknowledged market leader, will join us to lead our Hong Kong law practice,” Cleary managing partner Mark Walker said in a statement. “Adding Hong Kong law capability to our existing, successful Asia practice is a natural and important extension of our firm’s global business model, which combines strong local law and international law practices around the world.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
